Abstract
Immunohistochemistry (IHC), also known as immunohistochemical staining, is an immune morphological analysis. It is a process of selectively identifying antigens (proteins) by antibodies in cells or tissue sections. This chapter introduces the procedure and application of immunohistochemistry. Although immunohistochemistry has a vast application in basic and clinical studies, this chapter focuses on its application in biomarker study, particularly in biomarkers that related to cancer diagnosis, prognosis, and drug development. Detail protocol of immunohistochemistry in formalin-fixed and paraffin-embedded tissue sections is included.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Coons AH, Creech HJ, Jones RN (1941) Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med 47:200–202
Childs GV (2014) History of immunohistochemistry. In: McManus LM, Mitchell RN (eds) Pathobiology of human disease. Elsevier, San Diego, pp 3775–3796
Lindenmann J (1984) Origin of the terms “antibody” and “antigen”. Scand J Immunol 19(4):281–285
The Nobel Prize in Physiology or Medicine (1901) nobelprize.org. https://www.nobelprize.org/prizes/medicine/1901/summary/
The Nobel Prize in Physiology or Medicine (1908) nobelprize.org. https://www.nobelprize.org/prizes/medicine/1908/summary/
Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95
Khleif SN, Doroshow JH, Hait WN, AACR-FDA-NCI Cancer Biomarkers Collaborative (2010) AACR-FDA-NCI. Cancer biomarkers collaborative consensus report: advancing the use of biomarkers in cancer drug development. Clin Cancer Res 16:3299–3318
Smith NR, Womack C (2014) A matrix approach to guide IHC-based tissue biomarker development in oncology drug discovery. J Pathol 232(2):190–198
Howat WJ, Lewis A, Jones P et al (2014) Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical based histopathology researchers. Methods 70(1):34–38
Shi SR, Liu C, Taylor CR (2007) Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis. J Histochem Cytochem 55(2):105–109
Zu W, Li A, Chen T (2015) Rabbit monoclonal antibody. In: Fan L, Jeffrey P (eds) Handbook of practical immunohistochemistry: frequently asked questions, 2nd edn. Springer, New York
Schacht V, Kern JS (2015) Basics of immunohistochemistry. J Invest Dermatol 135:e30
Werner M, Chott A, Fabiano A et al (2000) Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 24(7):1016–1019
Grizzle WE (2009) Models of fixation and tissue processing. Biotech Histochem 84(5):185–193
Taylor CR, Shi SR et al (1996) Comparative study of antigen retrieval heating methods: microwave, microwave and pressure cooker, autoclave, and steamer. Biotech Histochem 71(5):263–270
Lott R, Tunnicliffe J, Sheppard E et al (2015) Practical guide to specimen handling in surgical pathology. College of American Pathologist, Northfield, IL
Yang DH, Smith ER, Roland IH, Sheng Z, He J, Martin WD, Hamilton TC, Lambeth JD, Xu XX (2002) Disabled-2 is essential for endodermal cell positioning and structural formation during mouse embryogenesis. Dev Biol 251:27–44
Yang DH, Kasamo H, Miyauchi M, Tsuyama S, Murata F (1996) Ontogeny of sulfated glycoconjugate producing cells in the rat fundic gland. Histochem J 28:33–43
Yang DH, Tsuyama S, Ge Y-B, Ohmori J, Wakamatsu D, Murata F (1997) Proliferation and migration kinetics of stem cells in the rat fundic gland. Histol Histopathol 12:717–728
Yang DH, Tsuyama S, Ohmori J, Hotta K, Katsuyama T, Murata F (1999) Phenotypic immunostaining of mucus-secreting cells of foregut origin. Acta Histochem Cytochem 32(2):135–140
Yang DH, Tsuyama S, Murata F (2001) The expression of gastric H-K-ATPase mRNA and protein in develo** rat fundic gland. Histochem J 33:159–166
Yang DH, Tsuyama S, Hotta K, Katsuyama T, Murata F (2000) Expression of N-acetylglucosamine residues in develo** rat fundic gland cells. Histochem J 32(3):187–193
Yang DH, Moss EG (2003) Temporally regulated expression of Lin-28 in diverse tissue of the develo** mouse. Gene Expr Patterns 3(6):719–726
Yang DH, Smith ER, Cohen C, Patriotis C, Godwin AK, Hamilton TC, Xu XX (2002) Molecular events associated with dysplastic morphological transformation and initiation of ovarian tumorigenicity. Cancer 94:2380–2392
Yang DH, Fazili Z, Smith ER, Cai Q, Klein-Szanto A, Cohen C, Horowitz IR, Xu XX (2006) Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53 null background. Am J Pathol 169:258–267
Yang DH, Cai KQ, Roland IH, Smith ER, Xu XX (2007) Disabled-2 is an epithelial surface positioning gene. J Biol Chem 282(17):13114–13122
Yang DH, Smith ER, Cai KQ, Xu XX (2009) c-fos elimination compensates for disabled-2 requirement in mouse extraembryonic endoderm development. Dev Dyn 238(3):514–523
Yang DH, McKee KK, Chen ZL, Mernaugh G, Strickland S, Zent R, Yurchenco PD (2011) Renal collecting system growth and function depend upon embryonic gamma1 laminin expression. Development 138(20):4535–4544
Khan SA, Yang DH, Zhu F, Dubyk C, Tejani M, Cohen SJ, Hoffman JP, Burtness BA (2012) Survivin expression with resected pancreatic adenocarcinoma. Cancer Res 72(8):714–714
Keller LM, Galloway TJ, Holdbrook T, Ruth K, Yang DH, Dubyk C, Flieder D, Lango MN, Mehra R, Burtness B, Ridge JA (2013) p16 status, pathologic and clinical characteristics, biomolecular signature, and long term outcomes in unknown primary carcinomas of the head and neck. Head Neck 36(12):1677–1684
Mekee KK, Yang DH, Patel R, Chen ZL, Strickland S, Takagi J, Sekiguchi K, Yurchenco PD (2012) Schwann cell myelination requires integration of laminin activities. J Cell Sci 125(Pt 19):4609–4619. https://doi.org/10.1242/jcs.107995. #equal contribution 1st author
Sukhanova A, Gorin A, Serebriiskii IG, Gabitova L, Zheng H, Restifo D, Egleston BL, Cunningham D, Bagnyukova T, Liu H, Nikonova A, Adams GP, Zhou Y, Yang DH, Mehra R, Burtness B, Cai KQ, Klein-Szanto A, Kratz LE, Kelley RI, Weiner LM, Herman GE, Golemis EA, Astsaturov IA (2013) Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGFR inhibitors via increased EGFR degradation. Cancer Discov 3(1):96–111. https://doi.org/10.1158/2159-8290.CD-12-0031.
Gabitova L, Restifo D, Gorin A, Manocha K, Handorf E, Yang DH, Cai K, Klein-Szanto AS, Cunningham D, Kratz L, Herman G, Golemis EA, Astsaturov I (2015) Endogenous sterol metabolites regulate growth of EGFR/KRAS-dependent tumors via LXR. Cell Rep 12(11):1927–1938. https://doi.org/10.1016/j.celrep.2015.08.023
Kudinov A, Deneka A, Nikonova A, Beck T, Ahn Y, Liu X, Yang DH, Golemis E, Boumber Y (2016) Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl Acad Sci U S A 113(25):6955–6960. https://doi.org/10.1073/pnas.1513616113
Sodani K, Patel A, Anreddy N, Singh S, Yang DH, Kathawala RJ, Kumar P, Talele TT, Chen ZS (2014) Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochem Pharmacol 89(1):52–61
Mehra R, Zhu F, Yang DH, Cai KQ, Weaver J, Singh MK, Nikonova A, Golemis EA, Flieder DB, Cooper H, Lango MN, Ridge JA, Burtness B (2013) Quantification of excision repair cross complementing group 1 (ERCC1) and survival in p16-negative squamous cell head and neck cancers. Clin Cancer Res 19(23):6633–6643
Egloff AM, Lee JW, Langer C, Quon H, Vaezi A, Grandis JR, Seethala RR, Wang L, Shin DM, Argiris A, Yang DH, Mehra R, Ridge JA, Patel UA, Burtness B, Forastiere AA (2014) Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group trial E3303. Clin Cancer Res 20(19):5041–5051
Lee JW, Parameswaran J, Sandoval-Schaefer T, Eoh KJ, Yang DH, Zhu F, Mehra R, Sharma R, Gaffney SG, Perry EB, Townsend JP, Serebriiskii IG, Golemis EA, Issaeva N, Yarbrough WG, Koo JS, Burtness BA (2019) Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck. Clin Cancer Res 25(11):3430–3442
Xu S, Yao H, Luo S, Zhang YK, Yang DH, Li D, Wang G, Hu M, Yao H∗, Wu X, Chen ZS, Xu J. (2017) A potent anticancer optimized from natural oridonin scaffold induces apoptosis and cell cycle arrest through the mitochondrial pathway, J Med Chem, 60(4):1449-1468. doi: https://doi.org/10.1021/acs.jmedchem.6b01652
Pileri SA, Roncador G et al (1997) Antigen retrieval techniques in immunohistochemistry: a comparison of different methods. J Pathol 183(1):116–123
O’Leary TJ (2001) Standardization in immunohistochemistry. Appl Immunohistochem Mol Morphol 9(1):3–8
Lin F, Chen Z (2014) Standardization of diagnostic immunohistochemistry: literature review and geisinger experience. Arch Pathol Lab Med 138(12):1564–1577
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Li, A., Yang, DH. (2020). Application of Immunohistochemistry in Basic and Clinical Studies. In: Vancurova, I., Zhu, Y. (eds) Immune Mediators in Cancer. Methods in Molecular Biology, vol 2108. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0247-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0247-8_4
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0246-1
Online ISBN: 978-1-0716-0247-8
eBook Packages: Springer Protocols